A Close Examination of Patient Experiences in Bipolar Disorder Clinical Trials

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-06-30

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Participation in clinical trials usually favors a particular demographic group. But there is limited research available to explain what study attributes affect the completion of these specific demographic groups.

This study will investigate the safety and efficacy of bipolar disorder treatments. The focus will be on tracking the rates of completion and withdrawal among these individuals.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future bipolar disorder study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Understanding Treatment Adherence Among Individuals With Bipolar Disorder

NCT00183495

Bipolar Disorder

COMPLETED

Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)

NCT01395992

Bipolar I Disorder

COMPLETED PHASE3

Does Bipolar Disease Program (BDP) Intervention Improve Long Term Manic and Depressive Symptoms.

NCT00007761

Bipolar Disorder

COMPLETED PHASE3

Change in Brain Bioenergetics in Bipolar Disorder in Response to Photic Stimulation

NCT00801567

Bipolar Disorder Schizophrenia Healthy Controls

WITHDRAWN NA

A Compassionate-focused Intervention for Older People with Bipolar Disorder

NCT06882590

Bipolar Disorder I or II

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bipolar Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient is at least 18 years of age
* Diagnosis of bipolar disorder
* Ability to understand a written informed consent document, and the willingness to sign it.

Exclusion Criteria

* Women of childbearing potential without a negative pregnancy test; or women who are lactating.
* Has a serious medical or psychiatric illness likely to interfere with participation in this clinical study.
* Inability to perform regular electronic reporting

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No